"Anti-fat" drug could be available within four years

An "anti-fat" drug with a significant worldwide market potential could be available in four years, after tests on obese men showed encouraging results, according to the Australian pharmaceutical research company developing the drug.<BR />

Published By MarketLine

'Bat Saliva' trials give hope to stroke sufferers

Clinical trials conducted by Paion GmbH have demonstrated that a protein from bat saliva could offer a new treatment for strokes or brain attacks. Patients in the phase II study were treated with Desmoteplase, a genetically engineered version of a blood clot-dissolving protein found in the saliva of vampire bats.

Published By MarketLine

'Double suicide gene' therapy may offer safer treatment for prostate cancer

Published By MarketLine

'Gene pill' patent extended to include all proteins secreted into blood

Published By MarketLine

'Glowing' bacteria help St Jude researchers discover how anti-flu drug may prevent deadly bacterial pneumonia

Investigators at St. Jude Children's Research Hospital working on mice have shown how the potentially deadly cooperation between influenza virus and bacterial pneumonia infections can be foiled, even when treatment is delayed and flu levels in the lung have peaked.

Published By MarketLine

'Priority Review' status for Enbrel as treatment of psoriatic arthritis

Published By MarketLine

11-valent mixed carrier pneumococcal conjugate vaccine safe for small children

Published By MarketLine

1F7 shown to help bodies fight against HIV infection in pre-clinical study

Published By MarketLine

2-CDA tested in treatment of acute myelogenous leukemia

Published By MarketLine

3-D and Boehringer Ingelheim extend drug discovery collaboration

Published By MarketLine